CN1919844B - 水相氧化合成兰索拉唑的方法 - Google Patents
水相氧化合成兰索拉唑的方法 Download PDFInfo
- Publication number
- CN1919844B CN1919844B CN200610124437A CN200610124437A CN1919844B CN 1919844 B CN1919844 B CN 1919844B CN 200610124437 A CN200610124437 A CN 200610124437A CN 200610124437 A CN200610124437 A CN 200610124437A CN 1919844 B CN1919844 B CN 1919844B
- Authority
- CN
- China
- Prior art keywords
- flask
- filter cake
- refrigerator
- beaker
- take out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610124437A CN1919844B (zh) | 2006-09-01 | 2006-09-01 | 水相氧化合成兰索拉唑的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610124437A CN1919844B (zh) | 2006-09-01 | 2006-09-01 | 水相氧化合成兰索拉唑的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1919844A CN1919844A (zh) | 2007-02-28 |
CN1919844B true CN1919844B (zh) | 2010-05-12 |
Family
ID=37777720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610124437A Active CN1919844B (zh) | 2006-09-01 | 2006-09-01 | 水相氧化合成兰索拉唑的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1919844B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102659763B (zh) * | 2012-04-27 | 2014-01-22 | 南京优科生物医药研究有限公司 | 一种右旋兰索拉唑合成与纯化的方法 |
CN103288799B (zh) * | 2013-03-05 | 2015-05-20 | 宁夏康亚药业有限公司 | 兰索拉唑的合成方法及由该方法合成的兰索拉唑 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1418188A (zh) * | 2000-03-13 | 2003-05-14 | 埃斯特维化学股份有限公司 | 氧化硫醚基成为亚砜基的方法 |
CN1489585A (zh) * | 2001-02-02 | 2004-04-14 | ������ҩ��ҵ����˾ | 取代的2-(2-吡啶基甲基)亚磺酰基-1h-苯并咪唑化合物的生产方法 |
WO2004063188A1 (en) * | 2003-01-15 | 2004-07-29 | Cipla Limited | Paharmaceutical process and compounds prepared thereby |
US20040215021A1 (en) * | 2002-11-18 | 2004-10-28 | Anita Liberman | Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
CN1754879A (zh) * | 2004-09-30 | 2006-04-05 | 江苏豪森药业股份有限公司 | 咪唑类衍生物化合物及其盐和用途 |
-
2006
- 2006-09-01 CN CN200610124437A patent/CN1919844B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1418188A (zh) * | 2000-03-13 | 2003-05-14 | 埃斯特维化学股份有限公司 | 氧化硫醚基成为亚砜基的方法 |
CN1489585A (zh) * | 2001-02-02 | 2004-04-14 | ������ҩ��ҵ����˾ | 取代的2-(2-吡啶基甲基)亚磺酰基-1h-苯并咪唑化合物的生产方法 |
US20040215021A1 (en) * | 2002-11-18 | 2004-10-28 | Anita Liberman | Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
WO2004063188A1 (en) * | 2003-01-15 | 2004-07-29 | Cipla Limited | Paharmaceutical process and compounds prepared thereby |
CN1754879A (zh) * | 2004-09-30 | 2006-04-05 | 江苏豪森药业股份有限公司 | 咪唑类衍生物化合物及其盐和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1919844A (zh) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101475562B (zh) | 一种新方法的兰索拉唑化合物 | |
CN103232438B (zh) | 泮托拉唑钠和制法 | |
CN102382103A (zh) | 一种左旋泮托拉唑钠的制备及纯化方法 | |
CN103073536B (zh) | 一种艾普拉唑的制备方法 | |
CN1919844B (zh) | 水相氧化合成兰索拉唑的方法 | |
CN111592447A (zh) | 间苯二酚制备方法 | |
CN102675285A (zh) | 一种纯水相制备雷贝拉唑钠的方法 | |
CN104262326B (zh) | 一种泮托拉唑钠的制备方法 | |
CN102993181A (zh) | 埃索美拉唑的制备方法及埃索美拉唑盐的制备方法 | |
AU2084001A (en) | Improved omeprazole process and compositions thereof | |
CN107188915B (zh) | 一种塞拉菌素中间体的制备方法 | |
CN101268051B (zh) | 同位素取代的质子泵抑制剂 | |
CN102816149B (zh) | 一种高对映选择性合成(s)-奥美拉唑及其盐的制备方法 | |
CN110724091B (zh) | 一种6-(二氟甲基)-2-羟基吡啶-3-磺酰氯的合成方法 | |
CN110078728B (zh) | 一种阿维巴坦中间体、制备方法及其应用 | |
CN103923133B (zh) | 一种制备α-熊果苷的方法 | |
CN107663192B (zh) | 一种雷贝拉唑杂质的制备方法 | |
CN103664888B (zh) | 埃索美拉唑镁三水合物的制备方法 | |
CN106397198A (zh) | 一种5‑氯‑2,3‑二氢‑2‑羟基‑1‑氧代‑1h‑茚‑2‑羧酸甲酯的制备方法 | |
CN104803978A (zh) | 一种埃索美拉唑镁的制备方法 | |
CN103724325B (zh) | 制备亚磺酰基-1-氢-苯并咪唑衍生物的方法 | |
US20060270711A1 (en) | Tenatoprazole salts and process of preparation thereof | |
US20140275550A1 (en) | Lansoprazole compound and novel preparation method thereof | |
CN102952119A (zh) | 一种雷贝拉唑钠的制备方法 | |
CN101153006A (zh) | 葡萄糖酸钴及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YUEKANG PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: WUHAN INSTITUTE OF TECHNOLOGY Effective date: 20130114 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430074 WUHAN, HUBEI PROVINCE TO: 100176 DAXING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130114 Address after: 100176, Hongda Road, Beijing economic and Technological Development Zone, No. 6 Patentee after: Yuekang Pharmaceutical Group Co., Ltd. Address before: 430074 Wuhan, Hongshan Province District, hung Chu street, No. 693 Patentee before: Wuhan Institute of Technology |
|
CP01 | Change in the name or title of a patent holder |
Address after: 100176, Hongda Road, Beijing economic and Technological Development Zone, No. 6 Patentee after: Yuekang Pharmaceutical Group Co., Ltd. Address before: 100176, Hongda Road, Beijing economic and Technological Development Zone, No. 6 Patentee before: YOUCARE PHARMACEUTICAL GROUP CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |